NG-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice E. M. UrbańskaE. DrelewskaS. J. Czuczwar OriginalPaper Pages: 1145 - 1152
BMY-14802 reversed the σ receptor agonist-induced neck dystonia in rats K. OkumuraH. UjikeS. Kuroda OriginalPaper Pages: 1153 - 1161
Antipsychotics with inverse agonist activity at the dopamine D3 receptor N. GriffonC. PilonP. Sokoloff OriginalPaper Pages: 1163 - 1175
Chronic levodopa therapy enhances dopa absorption: Contribution to wearing-off M. MurataH. MizusawaI. Kanazawa OriginalPaper Pages: 1177 - 1185
Parenteral application of NADH in Parkinson's disease: Clinical improvement partially due to stimulation of endogenous levodopa biosynthesis W. KuhnTh. MüllerH. Przuntek OriginalPaper Pages: 1187 - 1193
Visual hallucinosis: The major clinical determinant of distorted chromatic contour perception in Parkinson's disease Th. BüttnerW. KuhnH. Przuntek OriginalPaper Pages: 1195 - 1204
α1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease T. MuramatsuS. MatsushitaS. Higuchi OriginalPaper Pages: 1205 - 1210
Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia H. TohgiT. AbeS. Takahashi OriginalPaper Pages: 1211 - 1220
Additive effects, but no synergistic interaction of stressful life-events and genetic loading in affective disorders J. FritzeB. SchneiderK. Maurer OriginalPaper Pages: 1221 - 1229
Abstracts Third congress of the european society for clinical neuropharmacology U. BonuccelliR. CeravoloN. Pavese Abstract Pages: I - LV